Department of Neuroscience
Trondheim, Norway
NCT Number: NCT02550015
The purpose of this study is to examine if high intensity interval training after stroke is more effective than standard care to increase maximal oxygen uptake, reduce known risk factors for recurrent stroke and improve function.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Trondheim, Norway
Stroke is a leading cause of adult disability. Well designed studies have shown that the majority of the stroke population have low aerobic capacity and many are inactive. This is negative for their health and well-being. Physical inactivity may increase their risk of having recurrent stroke.
The optimal training mode and intensity to improve aerobic capacity after stroke are not clear. High intensity interval training (ie. 90-95% of peak heart rate) has been proven to be more beneficial than moderate and low intensity exercise in order to improve maximal oxygen uptake in patients with cardiac disease. The response from this training on aerobic capacity and physical function in the stroke population are not known.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Uphill treadmill walking
Standard care
Time frame: 1 year after inclusion
A graded treadmill test of maximal oxygen uptake using a breath by breath ergospirometer
Time frame: 8 weeks and 12 months after inclusion
Blood pressure will be measured at rest
Time frame: 8 weeks and 12 months after inclusion
Walking speed (in minutes:seconds) will be measured with the 10 meter walk test and the Timed Up and Go test.
Time frame: 8 weeks and 12 months after inclusion
Using the ActivePal monitor attached to the participants non-affected leg information on position, walking and inactive time will be measured during 3 whole consecutive days.
Time frame: 8 weeks and 12 months after inclusion
Time frame: 8 weeks and 12 months after inclusion
The following blood tests will be taken: Hemoglobin, HDL, LDL, Cholesterol, Total Cholesterol, C peptides, Triglycerides and HbA1c
Time frame: 8 weeks and 12 months after inclusion
Time frame: 8 weeks and 12 months after inclusion
Time frame: 8 weeks and 12 months after inclusion
Time frame: 8 weeks and 12 months after inclusion
Walking distance (in meters) will be measured with the 6 minute walk test.
Time frame: 8 weeks and 12 months after inclusion
Gathered from the participants and their electronic journal system
Time frame: 8 weeks and 12 months after inclusion
The Stroke Impact Scale will be used to evaluate how the stroke has affected the participants' health and life in addition to the National Institute of Health Stroke scale
Time frame: 8 weeks and 12 months after inclusion
Hospital and Anxiety and Depression Scale will be used to get information about the participants level of anxiety and depression
Time frame: 8 weeks and 12 months after inclusion
Modified Rankin Scale (mRS)
Time frame: 8 weeks and 12 months after inclusion
Time frame: 8 weeks and 12 months after inclusion
Oxygen consumption will be measured at a standardized speed and inclination.
Norwegian University of Science and Technology
Other
The Effect of High Intensity Interval Training on Maximal Oxygen Uptake and Risk Factors for Recurrent Stroke
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT07736573
Brain Diseases, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial Details